KRAS
Top View
- Pathway Analysis of Commonly Expressed Genes Found in Primates and in Mouse During Naïve State of Pluripotenc Keggid Kegg Names
- The Role of the Rho GEF Arhgef2 in RAS Tumorigenesis
- The Small G-Proteins K-Ras, H-Ras, and N-Ras Function As GDP–GTP
- Structural Basis of Recognition of Farnesylated and Methylated Kras4b by Pdeδ
- Differential Activity of the KRAS Oncogene by Method of Activation: Implications for Signaling and Therapeutic Intervention
- Clinical Significance of HRAS and KRAS Genes Expression in Patients
- Developing Small Molecules That Inhibit K-Ras/GTP Binding Based on New
- Rheb Activates AMPK and Reduces P27kip1 Levels in Tsc2-Null Cells Via Mtorc1-Independent Mechanisms: Implications for Cell Proliferation and Tumorigenesis
- Understand KRAS and the Quest for Anti-Cancer Drugs
- Targeting DNA Damage Response and Repair to Enhance Therapeutic Index in Cisplatin-Based Cancer Treatment
- The Role of Wild-Type RAS in Oncogenic RAS Transformation
- An Oncogenic Mutant of RHEB, RHEB Y35N, Exhibits an Altered Interaction with BRAF Resulting in Cancer Transformation Jeffrey J
- Orexins/Hypocretins and Cancer: a Neuropeptide As Emerging Target
- KRAS Is a Novel Target for Melanoma and Contributes to Primary And
- GNAS Drives Pancreatic Tumourigenesis by Inducing PKA-Mediated SIK Suppression and Reprogramming Lipid Metabolism
- KRAS Interaction with RAF1 RAS-Binding Domain and Cysteine-Rich Domain Provides Insights Into RAS-Mediated RAF Activation
- Exploiting RAS Nucleotide Cycling As a Strategy for Drugging RAS-Driven Cancers
- GPCR Signaling As a Paradigm